Equity markets remain range-bound at 24,800–25,000, with short-term pullbacks amid foreign investor selling and tariff concerns. Anshul Saigal of Saigal Capital says long-term growth remains intact, advising investors to focus on strong businesses. While IT valuations appear expensive with weak growth, opportunities are better in defence, renewables, banking, capital goods, and manufacturing.Read More
US and India trade talks show promise. Donald Trump and Narendra Modi are highlighting progress. A deal may finalize by November. Market expert Chakri Lokapriya sees benefits for IT, pharma, and auto sectors. Export sectors are likely to gain first. GST cuts will boost consumption. Auto and tyre companies are well-positioned.Read More
Manish Chokhani of Enam Holdings cautions that Indian equities, particularly in FMCG, IT, and pharma, face potential derating without innovation and business model changes. He highlights overvaluation in high-growth sectors like QSR and EMS, while suggesting opportunities in PSU privatization. India needs new growth drivers to avoid a prolonged market consolidation.Read More
Infosys shares experienced a 2% surge, reaching Rs 1,535 on the BSE, ahead of its fifth share buyback meeting. Historically, Infosys shares have generally risen following buyback announcements. Market experts suggest that current valuations are more appealing, with the stock consolidating at lower levels.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
